Abbott showcases its life-changing POC tests and diagnostic tools at MEDLAB Middle East – Critical Care


Image: ID NOW (Photo courtesy of Abbott)

At MEDLAB Middle East 2022, Abbott (Lake Forest, Illinois, USA) showcased its portfolio of life-changing diagnostic tools and medical devices for point-of-care testing that helps manage patients with COVID-19, diabetes and cardiovascular disease. their comorbidities.

In its COVID-19 testing portfolio, Abbott introduced its ID NOW COVID-19 point-of-care molecular platform that combines the advantages of speed and accuracy for the fastest molecular results on the market. The ID NOW COVID-19 test returns positive results in 13 minutes or less to enable immediate clinical decisions during the patient’s first visit. The easy-to-use ID NOW platform is designed for near-patient, point-of-care use in a variety of healthcare environments. Abbott introduced its Panbio COVID-19 IgG/IgM rapid test device, an in vitro rapid diagnostic test for the qualitative detection of IgG and IgM antibodies against SARS-CoV-2 in human serum, plasma, venous blood and fingerstick whole blood, alongside the Panbio COVID-19 Ag Rapid Test Device that can identify potentially infectious patients with or without symptoms in 15 minutes.

Also on display was the Afinion 2 system, a compact, rapid, multi-assay analyzer that provides valuable testing close to the patient at the point-of-care for doctors’ offices and clinics, eliminating the need to send patients to the lab or to spend time tracking down their results. The Afinion 2 System provides quick and easy testing of quantitative determinations of HbA1c, Lipid Panel, ACR, and CRP, and can reliably transfer test information to an HIS or LIS system. The analyzer and test cartridges have been precision engineered, with each test cartridge containing an integrated sample collection device and all reagents needed for a single test.

At MEDLAB 2022, Abbott introduced the i-STAT family of products for a wide range of clinical settings, including the lightweight, portable, and easy-to-use i-STAT 1 blood analyzer that works with advanced test cartridge technology i-STAT. Together they create the i-STAT system – a point-of-care testing platform that provides healthcare professionals with diagnostic information when and where it is needed. Abbott also introduced the i-STAT Alinity, a portable, easy-to-use blood analyzer that provides real-time, lab-quality diagnostic test results. The i-STAT Alinity is the most advanced testing solution in the i-STAT family and features a more intuitive interface that further simplifies the testing process, allowing for minimal operator training.

Related links:

Source link

Comments are closed.